Even though we’re approaching the end of the year, the healthcare M&A market hasn’t dried up quite yet. On December 29, New Horizon Medical Solutions (NHMS) announced the acquisition of Applied Tissue Technologies‘ (ATT) business assets.
The sale of ATT’s assets includes a transparent negative pressure wound therapy device and micro grafting kit. ATT is a 25-year-old wound care company based in Boston, Massachusetts. The company has conducted research and development supported by the United States Department of Defense to help wounded warriors at the point of injury, in instances of prolonged field care and delayed evacuation and throughout advanced levels of military medical care.
NHMS is a leader in advanced wound care technologies, developing and delivering biologically derived human placental allograft products designed to meet the highest standards of safety, quality and performance. The company’s portfolio includes amniotic membranes, placental tissues and skin graft solutions for chronic wounds, surgical reconstruction, burns and orthopedic procedures. NHMS has recently expanded its offerings to include advanced diagnostic imaging technologies through a partnership with Kent Imaging.
Will Hall, CEO of NHMS, remarked, “Together, these and other recent additions to our portfolio begin to distinguish us from others and make us a formidable industry partner.”
This acquisition not only expands NHMS’s product offerings but also enhances its position as a leader in advanced wound care solutions. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this marks the 86th Medical Device transaction of 2025, as of December 30. This is pretty much on par with 2024, when there were 87 Medical Device deals announced.
The post New Horizon Medical Solutions Acquires Applied Tissue Technologies’ Business Assets appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
